Company Update
-
FDA announces clearance of Control-IQ technology as first in new category!
It’s here! Today, we’re so excited to announce that we received FDA clearance for our Control-IQ technology for the t:slim X2 insulin pump, designed to help increase time in range, as measured by CGM, by predicting and helping prevent both highs and lows.
Read Article -
Don’t wait! Tandem’s Jazzmin Bautista talks about using year-end benefits to get a new t:slim X2 pump
The year is winding down. If you have funds sitting in your flexible spending account (FSA) or a maxed-out insurance deductible, there could be a new t:slim X2 insulin pump out there with your name on it. You can wait for the next big approval by the FDA to order your pump, or you can boost your chances of getting your t:slim X2 pump for less out-of-pocket by taking a strategic, time-sensitive approach. With Tandem Diabetes Care, there’s no need to wait. Since today’s t:slim X2 insulin pump is built for tomorrow’s technologies, you can purchase your t:slim X2 insulin pump now...
Read Article -
Tandem Diabetes Care Sponsors Project 50-in-50 Mountaineering Expedition
Tandem announced its sponsorship of Project 50-in-50, a mountaineering challenge by two climbers with type 1 diabetes—Michael Shelver and Patrick Mertes. To achieve their goal, Shelver and Mertes will need to summit the highest peaks in each of the 50 United States in 50 days or less. Only two individuals have accomplished this before, none with type 1 diabetes.
Read Article -
Tandem Diabetes Care Supports Connected in Motion as National Sponsor
Today we announced announced our sponsorship of Connected in Motion’s 2019 program calendar, featuring social and educational programing that builds community among people with type 1 diabetes. The funding will go to support Slipstream Retreats, adventure programs, and special projects in Ontario, British Columbia, the Yukon, and Alberta, Canada, including additional support for the Ontario Slipstream Retreat, hosted in partnership with Beyond Type 1.
Read Article -
Tandem Diabetes Care Sponsors 2019 Beyond Type Run Team
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of Beyond Type 1’s “Beyond Type Run,” an official charity partner of the 2019 TCS New York City Marathon.
Read Article -
Tandem Diabetes Care Awards Sponsorship to the MyCareConnect Foundation
Today we announced our sponsorship of BlueLoop, a care coordination resource for children with type 1 diabetes. BlueLoop, powered by the non-profit MyCareConnect Foundation, is a tool to help improve a family's ability to manage a child’s diabetes when the child is at school or away from home.
Read Article
From time to time, we may pass along suggestions, tips, or information about other Tandem Diabetes Care insulin pump user experiences or approaches to the management of diabetes. Please note individual symptoms, situations, circumstances, and results may vary. Please consult your physician or qualified healthcare provider regarding your condition and appropriate medical treatment. Please read the Important Safety Information before using our products.